Skip to main content

Table 1 Laboratory characteristics of the participants

From: Single and combined use of red cell distribution width, mean platelet volume, and cancer antigen 125 for differential diagnosis of ovarian cancer and benign ovarian tumors

Variables

ovarian cancer

benign ovarian tumors

controls

P-value

Number

326

290

162

 

Age(years)

43.15 ± 11.59

43.18 ± 9.25

44.13 ± 6.90

0.544

W; (109/L)

8.28 ± 4.01a

6.69 ± 2.25

6.33 ± 1.49c

<0.001

N; (109/L)

6.11 ± 4.04a

4.12 ± 2.01

3.70 ± 1.12c

<0.001

L; (109/L)

1.52 ± 0.68a

1.97 ± 0.67

2.07 ± 0.72c

<0.001

Mo; (109/L)

0.49 ± 0.01a

0.45 ± 0.15

0.44 ± 0.15c

0.001

Hb; (g/L)

106.38 ± 19.53a

124.64 ± 13.13

128.14 ± 6.47c

<0.001

PLT; (1012/L)

216.50 ± 130.92a

239.68 ± 88.08

248.18 ± 64.8c

0.001

MPV; (fl)

8.19 ± 0.86a

9.31 ± 0.91b

9.64 ± 0.63c

<0.001

PDW;(%)

0.16 ± 0.01a

0.16 ± 0.02b

0.16 ± 0.01c

<0.001

RDW;(%)

0.16 ± 0.02a

0.14 ± 0.01b

0.13 ± 0.01c

<0.001

CA125; U/mL

68.85(32.20–385.05)a

23.15(14.43–37.76)

5.94(4.04–13.94)c

<0.001

  1. Data are expressed as mean ± standard deviation or median (interquartile range)
  2. W, white blood cell count; N, absolute neutrophil count; L, absolute lymphocyte count; Mo, absolute monocyte count; Hb, hemoglobin; PLT, blood platelet count; MPV, mean platelet volume; PDW, platelet distribution width; RDW, red cell distribution width; CA125, cancer antigen 125
  3. P values were calculated by one-way ANOVA tests
  4. aIndicates a significant difference (P < 0.05) between ovarian cancer and benign ovarian tumors (Tukey’s test)
  5. bIndicates a significant difference (P < 0.05) between benign ovarian tumors and controls (Tukey’s test)
  6. cIndicates a significant difference (P < 0.05) between ovarian cancer and controls (Tukey’s test)
  7. 109,10^9; 1012,10^12